Paxman secures first UK orders for neuropathy system
Bitget2026/10/30 11:02- Paxman secured first UK orders for four neuropathy systems from a private cancer care provider within a major international healthcare group.
- The systems will be installed at four UK locations in December 2026, marking the product's first commercial installations in the country.
- The orders mark the company's first expansion beyond scalp cooling into managing chemotherapy-induced peripheral neuropathy.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Indonesian Rupiah: External headwinds and MSCI risks – OCBC
Taiwan Dollar: Strong fundamentals but near-term pressure – Commerzbank
Hassett Downplays AI Debt Risk: The Industry Has Sufficient Funds, No Risk of Broad Sell-Off
Kevin Hassett, Director of the White House National Economic Council, stated that the recent substantial decline in technology stocks does not indicate a comprehensive sell-off risk for the AI industry. He acknowledged that some enterprises are indeed burdened with significant debt, which warrants attention. However, he also pointed out that there are many financially strong companies within the industry that hold both equity and debt in related firms; these companies may be poised to acquire or provide funding support when opportunities arise.
Crypto prices
More
